Bank of New York Mellon’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $721K | Sell |
200,151
-2,965
| -1% | -$10.7K | ﹤0.01% | 3289 |
|
|
2025
Q1 | $607K | Sell |
203,116
-8,914
| -4% | -$26.7K | ﹤0.01% | 3334 |
|
|
2024
Q4 | $710K | Sell |
212,030
-660
| -0.3% | -$2.21K | ﹤0.01% | 3321 |
|
|
2024
Q3 | $713K | Sell |
212,690
-53,494
| -20% | -$179K | ﹤0.01% | 3311 |
|
|
2024
Q2 | $881K | Buy |
266,184
+26,627
| +11% | +$88.1K | ﹤0.01% | 3268 |
|
|
2024
Q1 | $968K | Sell |
239,557
-15,731
| -6% | -$63.6K | ﹤0.01% | 3164 |
|
|
2023
Q4 | $779K | Sell |
255,288
-66,120
| -21% | -$202K | ﹤0.01% | 3318 |
|
|
2023
Q3 | $964K | Buy |
321,408
+103
| +0% | +$309 | ﹤0.01% | 3173 |
|
|
2023
Q2 | $1.2M | Buy |
321,305
+11,746
| +4% | +$43.9K | ﹤0.01% | 3096 |
|
|
2023
Q1 | $1.04M | Sell |
309,559
-10,987
| -3% | -$36.8K | ﹤0.01% | 3114 |
|
|
2022
Q4 | $1.54M | Buy |
320,546
+13,690
| +4% | +$65.8K | ﹤0.01% | 2987 |
|
|
2022
Q3 | $1.75M | Buy |
306,856
+36,812
| +14% | +$209K | ﹤0.01% | 2931 |
|
|
2022
Q2 | $1.92M | Sell |
270,044
-6,682
| -2% | -$47.4K | ﹤0.01% | 2850 |
|
|
2022
Q1 | $2M | Sell |
276,726
-1,067
| -0.4% | -$7.7K | ﹤0.01% | 2945 |
|
|
2021
Q4 | $2.48M | Buy |
277,793
+18,519
| +7% | +$166K | ﹤0.01% | 2860 |
|
|
2021
Q3 | $9.09M | Buy |
259,274
+62,999
| +32% | +$2.21M | ﹤0.01% | 2178 |
|
|
2021
Q2 | $4.22M | Buy |
196,275
+152,038
| +344% | +$3.27M | ﹤0.01% | 2566 |
|
|
2021
Q1 | $2.73M | Buy |
44,237
+7,418
| +20% | +$458K | ﹤0.01% | 2745 |
|
|
2020
Q4 | $1.54M | Buy |
+36,819
| New | +$1.54M | ﹤0.01% | 2990 |
|